Gsa Capital Partners LLP Macrogenics Inc Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Macrogenics Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 207,877 shares of MGNX stock, worth $677,679. This represents 0.05% of its overall portfolio holdings.

Number of Shares

207,877

Previous 95,689 117.24%

Holding current value

$677,679

Previous $407,000 68.06%

% of portfolio

0.05%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$3.0 - $5.55 $336,564 - $622,643	112,188 Added 117.24%	207,877 $684,000
Q2 2024 Aug 15, 2024	BUY	$3.31 - $18.51 $316,730 - $1.77 Million	95,689 New	95,689 $407,000
Q4 2023 Feb 16, 2024	SELL	$4.48 - $10.11 $457,864 - $1.03 Million	-102,202 Reduced 45.24%	123,716 $1.19 Million
Q3 2023 Nov 15, 2023	BUY	$4.48 - $6.19 $433,484 - $598,944	96,760 Added 74.92%	225,918 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$4.62 - $7.54 $413,965 - $675,606	89,603 Added 226.53%	129,158 $690,000
Q1 2023 May 12, 2023	SELL	$4.82 - $7.24 $86,996 - $130,674	-18,049 Reduced 31.33%	39,555 $283,000
Q4 2022 Feb 13, 2023	BUY	$3.34 - $6.98 $192,397 - $402,075	57,604 New	57,604 $387,000
Q2 2022 Aug 09, 2022	BUY	$2.25 - $9.99 $29,961 - $133,026	13,316 New	13,316 $39,000
Q1 2022 May 11, 2022	SELL	$8.12 - $16.9 $185,923 - $386,959	-22,897 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $364,291 - $500,986	22,897 New	22,897 $367,000
Q2 2020 Aug 11, 2020	SELL	$5.2 - $29.12 $286,104 - $1.6 Million	-55,020 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$4.28 - $12.11 $123,341 - $348,985	-28,818 Reduced 34.37%	55,020 $320,000
Q4 2019 Feb 12, 2020	BUY	$7.95 - $12.27 $392,730 - $606,138	49,400 Added 143.45%	83,838 $912,000
Q3 2019 Nov 12, 2019	BUY	$12.44 - $17.48 $235,974 - $331,578	18,969 Added 122.63%	34,438 $439,000
Q2 2019 Aug 06, 2019	BUY	$14.51 - $19.71 $224,455 - $304,893	15,469 New	15,469 $263,000
Q2 2018 Aug 09, 2018	SELL	$19.78 - $24.67 $377,798 - $471,197	-19,100 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$18.89 - $32.46 $360,799 - $619,986	19,100 New	19,100 $481,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Macrogenics Inc Transaction History